KR20090074754A - 포장재 - Google Patents
포장재 Download PDFInfo
- Publication number
- KR20090074754A KR20090074754A KR1020097006803A KR20097006803A KR20090074754A KR 20090074754 A KR20090074754 A KR 20090074754A KR 1020097006803 A KR1020097006803 A KR 1020097006803A KR 20097006803 A KR20097006803 A KR 20097006803A KR 20090074754 A KR20090074754 A KR 20090074754A
- Authority
- KR
- South Korea
- Prior art keywords
- packaging material
- density polyethylene
- low density
- layer
- pack
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims description 28
- 238000012856 packing Methods 0.000 title description 6
- 239000003463 adsorbent Substances 0.000 claims abstract description 41
- 238000004806 packaging method and process Methods 0.000 claims abstract description 12
- 239000010410 layer Substances 0.000 claims description 101
- 239000005022 packaging material Substances 0.000 claims description 72
- 238000001179 sorption measurement Methods 0.000 claims description 54
- 238000000034 method Methods 0.000 claims description 48
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 43
- -1 polypropylene Polymers 0.000 claims description 40
- 239000010457 zeolite Substances 0.000 claims description 38
- 229910021536 Zeolite Inorganic materials 0.000 claims description 37
- 238000009472 formulation Methods 0.000 claims description 37
- 239000000203 mixture Substances 0.000 claims description 37
- 239000004743 Polypropylene Substances 0.000 claims description 31
- 229920001155 polypropylene Polymers 0.000 claims description 31
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 25
- 229920001684 low density polyethylene Polymers 0.000 claims description 25
- 239000004702 low-density polyethylene Substances 0.000 claims description 25
- 229920000092 linear low density polyethylene Polymers 0.000 claims description 21
- 239000004707 linear low-density polyethylene Substances 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 20
- 239000000565 sealant Substances 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 14
- 230000002209 hydrophobic effect Effects 0.000 claims description 10
- 239000004800 polyvinyl chloride Substances 0.000 claims description 10
- 239000000377 silicon dioxide Substances 0.000 claims description 10
- 239000012790 adhesive layer Substances 0.000 claims description 9
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 239000005038 ethylene vinyl acetate Substances 0.000 claims description 7
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 7
- 229920000089 Cyclic olefin copolymer Polymers 0.000 claims description 6
- 239000004713 Cyclic olefin copolymer Substances 0.000 claims description 6
- 239000005033 polyvinylidene chloride Substances 0.000 claims description 6
- 229920001328 Polyvinylidene chloride Polymers 0.000 claims description 5
- 229920006242 ethylene acrylic acid copolymer Polymers 0.000 claims description 5
- 229920006228 ethylene acrylate copolymer Polymers 0.000 claims description 4
- 229920005648 ethylene methacrylic acid copolymer Polymers 0.000 claims description 4
- 229920005680 ethylene-methyl methacrylate copolymer Polymers 0.000 claims description 4
- PEPQUBUZFYZZET-UHFFFAOYSA-N ethene;prop-2-enoic acid Chemical compound C=C.C=C.OC(=O)C=C PEPQUBUZFYZZET-UHFFFAOYSA-N 0.000 claims description 3
- 229920000554 ionomer Polymers 0.000 claims description 3
- 229920006225 ethylene-methyl acrylate Polymers 0.000 claims description 2
- ODCGXIDLDHZBBZ-UHFFFAOYSA-N C=C.ClF Chemical compound C=C.ClF ODCGXIDLDHZBBZ-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 7
- 235000019645 odor Nutrition 0.000 description 25
- 229920005989 resin Polymers 0.000 description 15
- 239000011347 resin Substances 0.000 description 15
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 9
- 125000002541 furyl group Chemical group 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- 229910052782 aluminium Inorganic materials 0.000 description 7
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 7
- 125000005541 phosphonamide group Chemical group 0.000 description 7
- 239000000049 pigment Substances 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 6
- 238000001125 extrusion Methods 0.000 description 6
- 238000003475 lamination Methods 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229920005992 thermoplastic resin Polymers 0.000 description 5
- 239000004594 Masterbatch (MB) Substances 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- 239000002274 desiccant Substances 0.000 description 4
- 238000009820 dry lamination Methods 0.000 description 4
- 239000011888 foil Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000004576 sand Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 239000004952 Polyamide Substances 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 229920002647 polyamide Polymers 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- 229920001342 Bakelite® Polymers 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- UQGKUQLKSCSZGY-UHFFFAOYSA-N Olmesartan medoxomil Chemical compound C=1C=C(C=2C(=CC=CC=2)C2=NNN=N2)C=CC=1CN1C(CCC)=NC(C(C)(C)O)=C1C(=O)OCC=1OC(=O)OC=1C UQGKUQLKSCSZGY-UHFFFAOYSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 241000220259 Raphanus Species 0.000 description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 2
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 208000020832 chronic kidney disease Diseases 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000011990 functional testing Methods 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000010030 laminating Methods 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 229960001199 olmesartan medoxomil Drugs 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000009823 thermal lamination Methods 0.000 description 2
- 238000009816 wet lamination Methods 0.000 description 2
- ZGGHKIMDNBDHJB-NRFPMOEYSA-M (3R,5S)-fluvastatin sodium Chemical compound [Na+].C12=CC=CC=C2N(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 ZGGHKIMDNBDHJB-NRFPMOEYSA-M 0.000 description 1
- PVHUJELLJLJGLN-INIZCTEOSA-N (S)-nitrendipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC([N+]([O-])=O)=C1 PVHUJELLJLJGLN-INIZCTEOSA-N 0.000 description 1
- FAFVVBJEQCPDIA-UHFFFAOYSA-N 1-[4-amino-2,6-di(propan-2-yl)phenyl]-3-[1-butyl-4-[3-(3-hydroxypropoxy)phenyl]-2-oxo-1,8-naphthyridin-3-yl]urea;hydrochloride Chemical compound Cl.CC(C)C=1C=C(N)C=C(C(C)C)C=1NC(=O)NC=1C(=O)N(CCCC)C2=NC=CC=C2C=1C1=CC=CC(OCCCO)=C1 FAFVVBJEQCPDIA-UHFFFAOYSA-N 0.000 description 1
- TXIIZHHIOHVWJD-UHFFFAOYSA-N 2-[7-(2,2-dimethylpropanoylamino)-4,6-dimethyl-1-octyl-2,3-dihydroindol-5-yl]acetic acid Chemical compound CC(C)(C)C(=O)NC1=C(C)C(CC(O)=O)=C(C)C2=C1N(CCCCCCCC)CC2 TXIIZHHIOHVWJD-UHFFFAOYSA-N 0.000 description 1
- NSVFSAJIGAJDMR-UHFFFAOYSA-N 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate Chemical compound CC=1NC(C)=C(C(=O)OCCN(CC=2C=CC=CC=2)C=2C=CC=CC=2)C(C=2C=C(C=CC=2)[N+]([O-])=O)C=1P1(=O)OCC(C)(C)CO1 NSVFSAJIGAJDMR-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- ULXKXLZEOGLCRJ-UHFFFAOYSA-N 2-azaniumyl-3-ethylsulfanylpropanoate Chemical compound CCSCC(N)C(O)=O ULXKXLZEOGLCRJ-UHFFFAOYSA-N 0.000 description 1
- WBHAUHHMPXBZCQ-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound COC1=CC=CC(C)=C1O WBHAUHHMPXBZCQ-UHFFFAOYSA-N 0.000 description 1
- IETKPTYAGKZLKY-UHFFFAOYSA-N 5-[[4-[(3-methyl-4-oxoquinazolin-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione Chemical compound N=1C2=CC=CC=C2C(=O)N(C)C=1COC(C=C1)=CC=C1CC1SC(=O)NC1=O IETKPTYAGKZLKY-UHFFFAOYSA-N 0.000 description 1
- RZTAMFZIAATZDJ-HNNXBMFYSA-N 5-o-ethyl 3-o-methyl (4s)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC(Cl)=C1Cl RZTAMFZIAATZDJ-HNNXBMFYSA-N 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 description 1
- ZKFQEACEUNWPMT-UHFFFAOYSA-N Azelnidipine Chemical compound CC(C)OC(=O)C1=C(C)NC(N)=C(C(=O)OC2CN(C2)C(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZKFQEACEUNWPMT-UHFFFAOYSA-N 0.000 description 1
- BWSSMIJUDVUASQ-UHFFFAOYSA-N Benzylhydrochlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(S(N2)(=O)=O)=C1NC2CC1=CC=CC=C1 BWSSMIJUDVUASQ-UHFFFAOYSA-N 0.000 description 1
- 239000002051 C09CA08 - Olmesartan medoxomil Substances 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 description 1
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- KJEBULYHNRNJTE-DHZHZOJOSA-N Cinalong Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC\C=C\C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 KJEBULYHNRNJTE-DHZHZOJOSA-N 0.000 description 1
- UQQCAXMSWRLMQP-UHFFFAOYSA-N Cl.[S] Chemical compound Cl.[S] UQQCAXMSWRLMQP-UHFFFAOYSA-N 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 229920010126 Linear Low Density Polyethylene (LLDPE) Polymers 0.000 description 1
- IRLWJILLXJGJTD-UHFFFAOYSA-N Muraglitazar Chemical compound C1=CC(OC)=CC=C1OC(=O)N(CC(O)=O)CC(C=C1)=CC=C1OCCC1=C(C)OC(C=2C=CC=CC=2)=N1 IRLWJILLXJGJTD-UHFFFAOYSA-N 0.000 description 1
- WGZDBVOTUVNQFP-UHFFFAOYSA-N N-(1-phthalazinylamino)carbamic acid ethyl ester Chemical compound C1=CC=C2C(NNC(=O)OCC)=NN=CC2=C1 WGZDBVOTUVNQFP-UHFFFAOYSA-N 0.000 description 1
- OKJHGOPITGTTIM-DEOSSOPVSA-N Naveglitazar Chemical compound C1=CC(C[C@H](OC)C(O)=O)=CC=C1OCCCOC(C=C1)=CC=C1OC1=CC=CC=C1 OKJHGOPITGTTIM-DEOSSOPVSA-N 0.000 description 1
- ZBBHBTPTTSWHBA-UHFFFAOYSA-N Nicardipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZBBHBTPTTSWHBA-UHFFFAOYSA-N 0.000 description 1
- 239000005480 Olmesartan Substances 0.000 description 1
- TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 description 1
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229960000528 amlodipine Drugs 0.000 description 1
- HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 229960005370 atorvastatin Drugs 0.000 description 1
- 229950004646 azelnidipine Drugs 0.000 description 1
- 229960002992 barnidipine Drugs 0.000 description 1
- VXMOONUMYLCFJD-DHLKQENFSA-N barnidipine Chemical compound C1([C@@H]2C(=C(C)NC(C)=C2C(=O)OC)C(=O)O[C@@H]2CN(CC=3C=CC=CC=3)CC2)=CC=CC([N+]([O-])=O)=C1 VXMOONUMYLCFJD-DHLKQENFSA-N 0.000 description 1
- 229960004916 benidipine Drugs 0.000 description 1
- QZVNQOLPLYWLHQ-ZEQKJWHPSA-N benidipine Chemical compound C1([C@H]2C(=C(C)NC(C)=C2C(=O)OC)C(=O)O[C@H]2CN(CC=3C=CC=CC=3)CCC2)=CC=CC([N+]([O-])=O)=C1 QZVNQOLPLYWLHQ-ZEQKJWHPSA-N 0.000 description 1
- 229950007003 benzylhydrochlorothiazide Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 229960005110 cerivastatin Drugs 0.000 description 1
- SEERZIQQUAZTOL-ANMDKAQQSA-N cerivastatin Chemical compound COCC1=C(C(C)C)N=C(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 SEERZIQQUAZTOL-ANMDKAQQSA-N 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003020 cilnidipine Drugs 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- NIJJYAXOARWZEE-UHFFFAOYSA-N di-n-propyl-acetic acid Natural products CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- GJQPMPFPNINLKP-UHFFFAOYSA-N diclofenamide Chemical compound NS(=O)(=O)C1=CC(Cl)=C(Cl)C(S(N)(=O)=O)=C1 GJQPMPFPNINLKP-UHFFFAOYSA-N 0.000 description 1
- 229960005081 diclofenamide Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 229950003102 efonidipine Drugs 0.000 description 1
- HGVPOWOAHALJHA-UHFFFAOYSA-N ethene;methyl prop-2-enoate Chemical compound C=C.COC(=O)C=C HGVPOWOAHALJHA-UHFFFAOYSA-N 0.000 description 1
- 229940031005 ethyl cysteine Drugs 0.000 description 1
- 239000005043 ethylene-methyl acrylate Substances 0.000 description 1
- 229960003580 felodipine Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229960003765 fluvastatin Drugs 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229960002003 hydrochlorothiazide Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000005001 laminate film Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229960003963 manidipine Drugs 0.000 description 1
- ANEBWFXPVPTEET-UHFFFAOYSA-N manidipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(CC2)C(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ANEBWFXPVPTEET-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- PKWDZWYVIHVNKS-UHFFFAOYSA-N netoglitazone Chemical compound FC1=CC=CC=C1COC1=CC=C(C=C(CC2C(NC(=O)S2)=O)C=C2)C2=C1 PKWDZWYVIHVNKS-UHFFFAOYSA-N 0.000 description 1
- 229960001783 nicardipine Drugs 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960005425 nitrendipine Drugs 0.000 description 1
- SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 description 1
- 229960004872 nizatidine Drugs 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 229960005117 olmesartan Drugs 0.000 description 1
- VTRAEEWXHOVJFV-UHFFFAOYSA-N olmesartan Chemical compound CCCC1=NC(C(C)(C)O)=C(C(O)=O)N1CC1=CC=C(C=2C(=CC=CC=2)C=2NN=NN=2)C=C1 VTRAEEWXHOVJFV-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 238000012858 packaging process Methods 0.000 description 1
- 229950003510 pactimibe Drugs 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- PHUTUTUABXHXLW-UHFFFAOYSA-N pindolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=NC=C[C]12 PHUTUTUABXHXLW-UHFFFAOYSA-N 0.000 description 1
- 229960002508 pindolol Drugs 0.000 description 1
- 229960005095 pioglitazone Drugs 0.000 description 1
- 229960002797 pitavastatin Drugs 0.000 description 1
- VGYFMXBACGZSIL-MCBHFWOFSA-N pitavastatin Chemical compound OC(=O)C[C@H](O)C[C@H](O)\C=C\C1=C(C2CC2)N=C2C=CC=CC2=C1C1=CC=C(F)C=C1 VGYFMXBACGZSIL-MCBHFWOFSA-N 0.000 description 1
- 229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229960002965 pravastatin Drugs 0.000 description 1
- TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 description 1
- 229960001520 ranitidine hydrochloride Drugs 0.000 description 1
- GGWBHVILAJZWKJ-KJEVSKRMSA-N ranitidine hydrochloride Chemical compound [H+].[Cl-].[O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 GGWBHVILAJZWKJ-KJEVSKRMSA-N 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229960004586 rosiglitazone Drugs 0.000 description 1
- 229960000672 rosuvastatin Drugs 0.000 description 1
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229960002855 simvastatin Drugs 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- CXGTZJYQWSUFET-IBGZPJMESA-N tesaglitazar Chemical compound C1=CC(C[C@H](OCC)C(O)=O)=CC=C1OCCC1=CC=C(OS(C)(=O)=O)C=C1 CXGTZJYQWSUFET-IBGZPJMESA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229950001089 todralazine Drugs 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- LMJSLTNSBFUCMU-UHFFFAOYSA-N trichlormethiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NC(C(Cl)Cl)NS2(=O)=O LMJSLTNSBFUCMU-UHFFFAOYSA-N 0.000 description 1
- 229960004813 trichlormethiazide Drugs 0.000 description 1
- IRYJRGCIQBGHIV-UHFFFAOYSA-N trimethadione Chemical compound CN1C(=O)OC(C)(C)C1=O IRYJRGCIQBGHIV-UHFFFAOYSA-N 0.000 description 1
- 229960004453 trimethadione Drugs 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- MSRILKIQRXUYCT-UHFFFAOYSA-M valproate semisodium Chemical compound [Na+].CCCC(C(O)=O)CCC.CCCC(C([O-])=O)CCC MSRILKIQRXUYCT-UHFFFAOYSA-M 0.000 description 1
- 229960000604 valproic acid Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/10—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
- B01J20/16—Alumino-silicates
- B01J20/18—Synthetic zeolitic molecular sieves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
- B65D81/26—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
- B65D81/26—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators
- B65D81/266—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators for absorbing gases, e.g. oxygen absorbers or desiccants
- B65D81/267—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants with provision for draining away, or absorbing, or removing by ventilation, fluids, e.g. exuded by contents; Applications of corrosion inhibitors or desiccators for absorbing gases, e.g. oxygen absorbers or desiccants the absorber being in sheet form
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Composite Materials (AREA)
- Wrappers (AREA)
- Packages (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
비교예 1 | 실시예 1 | ||
25℃/60%RH | 오픈 | 2.2 | 0 |
필로우 포장 건조제 무 | 2.2 | 0 | |
필로우 포장 건조제 유 | 1.1 | 0 | |
40℃/75%RH | 필로우 포장 건조제 무 | 2.6 | 0 |
필로우 포장 건조제 유 | 0.3 | 0 |
Claims (30)
- 올메살탄메독소밀을 함유하는 제제를 포장하기 위한 포장재로서, 악취 흡착제를 함유하는 것을 특징으로 하는 포장재.
- 제 1 항에 있어서,악취 흡착제가 물리 흡착제 및 화학 흡착제에서 선택되는 화합물의 1 종 또는 2 종 이상인 포장재.
- 제 1 항에 있어서,악취 흡착제가 합성 제올라이트, 활성탄에서 선택되는 화합물의 1 종 또는 2 종 이상인 포장재.
- 제 1 항에 있어서,악취 흡착제가 합성 제올라이트 13X 인 포장재.
- 제 1 항에 있어서,악취 흡착제가 소수성 제올라이트인 포장재.
- 제 1 항에 있어서,악취 흡착제가 합성 제올라이트 13X 에 소수성 처리를 실시한 소수성 제올라이트인 포장재.
- 제 1 항에 있어서,악취 흡착제가 하이실리카 제올라이트인 포장재.
- 제 1 항 내지 제 7 항 중 어느 한 항에 있어서,포장재가 다층 필름인 포장재.
- 제 8 항에 있어서,다층 필름이 악취 흡착제를 함유하는 흡착층 및 기재층을 갖는 포장재.
- 제 9 항에 있어서,흡착층과 기재층 사이에 추가로 접착층을 갖는 포장재.
- 제 9 항 또는 제 10 항에 있어서,흡착층의 기재층과 대향하는 측에 추가로 실란트층을 갖는 포장재.
- 제 9 항 내지 제 11 항 중 어느 한 항에 있어서,흡착층의 기재층과 접하는 측에 추가로 외층을 갖는 포장재.
- 제 9 항 내지 제 12 항 중 어느 한 항에 있어서,흡착층이 저밀도 폴리에틸렌, 직사슬형 저밀도 폴리에틸렌, 폴리프로필렌, 아이오노머, 에틸렌아크릴산 공중합체, 에틸렌메타크릴산 공중합체, 에틸렌아세트산비닐 공중합체, 에틸렌에틸렌아크릴레이트 공중합체, 에틸렌메틸아크릴레이트 공중합체, 에틸렌메틸메타크릴레이트 공중합체에서 선택되는 화합물의 1 종 또는 2 종 이상을 함유하는 포장재.
- 제 9 항 내지 제 12 항 중 어느 한 항에 있어서,흡착층이 저밀도 폴리에틸렌, 직사슬형 저밀도 폴리에틸렌, 폴리프로필렌에서 선택되는 화합물의 1 종 또는 2 종 이상을 함유하는 포장재.
- 제 9 항 내지 제 12 항 중 어느 한 항에 있어서,흡착층이 저밀도 폴리에틸렌을 함유하는 포장재.
- 제 9 항 내지 제 15 항 중 어느 한 항에 있어서,기재층이 폴리염화비닐, 무연신 폴리프로필렌, 폴리프로필렌, 폴리염화비닐리덴, 폴리 3 불화염화에틸렌, 고리형 올레핀 공중합체에서 선택되는 화합물의 1 종 또는 2 종 이상을 함유하는 포장재.
- 제 9 항 내지 제 15 항 중 어느 한 항에 있어서,기재층이 폴리염화비닐을 함유하는 포장재.
- 제 10 항 내지 제 17 항 중 어느 한 항에 있어서,접착층이 저밀도 폴리에틸렌, 직사슬형 저밀도 폴리에틸렌, 폴리프로필렌에서 선택되는 화합물의 1 종 또는 2 종 이상을 함유하는 포장재.
- 제 10 항 내지 제 17 항 중 어느 한 항에 있어서,접착층이 저밀도 폴리에틸렌을 함유하는 포장재.
- 제 11 항 내지 제 19 항 중 어느 한 항에 있어서,실란트층이 저밀도 폴리에틸렌, 직사슬형 저밀도 폴리에틸렌, 폴리프로필렌에서 선택되는 화합물의 1 종 또는 2 종 이상을 함유하는 포장재.
- 제 11 항 내지 제 19 항 중 어느 한 항에 있어서,실란트층이 직사슬형 저밀도 폴리에틸렌을 함유하는 포장재.
- 제 12 항 내지 제 21 항 중 어느 한 항에 있어서,외층이 저밀도 폴리에틸렌, 직사슬형 저밀도 폴리에틸렌, 폴리프로필렌에서 선택되는 화합물의 1 종 또는 2 종 이상을 함유하는 포장재.
- 제 12 항 내지 제 21 항 중 어느 한 항에 있어서,외층이 직사슬형 저밀도 폴리에틸렌을 함유하는 포장재.
- 제 1 항 내지 제 23 항 중 어느 한 항에 기재된 포장재를 사용한 프레스 스루 팩 또는 블리스터 팩.
- 제 1 항 내지 제 23 항 중 어느 한 항에 기재된 포장재를 용기의 포켓 시트로 사용한 프레스 스루 팩 또는 블리스터 팩.
- 제 24 항 또는 제 25 항에 있어서,올메살탄메독소밀을 함유하는 제제를 포장한 프레스 스루 팩 또는 블리스터 팩.
- 제 1 항 내지 제 23 항 중 어느 한 항에 기재된 포장재로 포장된 올메살탄메독소밀 함유 제제.
- 제 24 항 또는 제 25 항에 기재된 프레스 스루 팩 또는 블리스터 팩으로 포장된 올메살탄메독소밀 함유 제제.
- 제 1 항 내지 제 23 항 중 어느 한 항에 기재된 포장재로 포장하는 것을 특징으로 하는 올메살탄메독소밀 함유 제제의 악취 방지 방법.
- 제 24 항 또는 제 25 항에 기재된 프레스 스루 팩 또는 블리스터 팩으로 포장하는 것을 특징으로 하는 올메살탄메독소밀 함유 제제의 악취 방지 방법.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2006-290033 | 2006-10-25 | ||
JP2006290033 | 2006-10-25 | ||
PCT/JP2007/070539 WO2008050714A1 (fr) | 2006-10-25 | 2007-10-22 | Matériel de conditionnement |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090074754A true KR20090074754A (ko) | 2009-07-07 |
KR101400653B1 KR101400653B1 (ko) | 2014-05-27 |
Family
ID=39324511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097006803A KR101400653B1 (ko) | 2006-10-25 | 2007-10-22 | 포장재 |
Country Status (5)
Country | Link |
---|---|
JP (2) | JP5241503B2 (ko) |
KR (1) | KR101400653B1 (ko) |
CN (1) | CN101528179B (ko) |
TW (2) | TWI402085B (ko) |
WO (1) | WO2008050714A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10994508B2 (en) | 2015-05-12 | 2021-05-04 | Innovia Films Limited | Film |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110303570A1 (en) * | 2009-03-02 | 2011-12-15 | Astellas Pharma Inc. | Package of solid pharmaceutical preparation |
TWI515113B (zh) * | 2010-09-01 | 2016-01-01 | Kyodo Printing Co Ltd | 積層體、包裝容器及包裝體 |
EP2612827A4 (en) * | 2010-09-01 | 2014-10-22 | Astellas Pharma Inc | PACKAGING |
CN102152543A (zh) * | 2010-12-14 | 2011-08-17 | 郑勇 | 具有铝箔漫反射面金属光泽的聚乙烯镀铝薄膜 |
JP5671397B2 (ja) * | 2011-03-30 | 2015-02-18 | 共同印刷株式会社 | 蓋材,包装容器及び包装体 |
MY167571A (en) * | 2012-03-01 | 2018-09-20 | Maruho Kk | Medicinal product package |
JP5849001B2 (ja) * | 2012-03-23 | 2016-01-27 | 第一三共株式会社 | Ptp又はブリスターパック用積層体、及びこれを用いて成形されたptp又はブリスターパック |
TW201347988A (zh) * | 2012-03-23 | 2013-12-01 | Daiichi Sankyo Co Ltd | Ptp或泡殼包裝用積層體及ptp或泡殼包裝 |
JP6421404B2 (ja) * | 2013-05-31 | 2018-11-14 | 大日本印刷株式会社 | 医薬品包装体 |
JP6927663B2 (ja) * | 2015-10-23 | 2021-09-01 | ニプロ株式会社 | 固形製剤包装体、及び固形製剤の臭い除去方法 |
KR102503428B1 (ko) * | 2015-12-22 | 2023-02-24 | 한미약품 주식회사 | 두타스테라이드를 포함하는 경구용 연질 캡슐 제형용 포장재 |
JP2018090298A (ja) * | 2016-12-05 | 2018-06-14 | 小林製薬株式会社 | ブリスターパッケージ |
EP3381548A1 (en) * | 2017-03-31 | 2018-10-03 | Clariant International Ltd | Adsorbent and packaging material |
JP6958030B2 (ja) * | 2017-07-04 | 2021-11-02 | 大日本印刷株式会社 | 低臭気積層体と該積層体からなる包装材料、及び該積層体の製造方法 |
JP6992358B2 (ja) * | 2017-09-22 | 2022-01-13 | 大日本印刷株式会社 | 低臭気積層体と該積層体からなる包装材料、及び該積層体の製造方法 |
CN114716758B (zh) | 2018-03-30 | 2024-08-23 | 大日本印刷株式会社 | 异味吸附成型品树脂组合物、异味吸附成型品以及包装材料 |
JP7143614B2 (ja) * | 2018-03-30 | 2022-09-29 | 大日本印刷株式会社 | 臭気吸着積層体及び臭気吸着性包装材料 |
CN109467848A (zh) * | 2018-11-07 | 2019-03-15 | 温州莲华环保科技有限公司 | 一种高吸附功能膜及其制备方法 |
JP7233213B2 (ja) * | 2018-12-13 | 2023-03-06 | 共同印刷株式会社 | ブリスターパック用積層体、それを用いたブリスターパック、及びブリスターパック包装体 |
CN110589228A (zh) * | 2019-08-02 | 2019-12-20 | 中山火炬职业技术学院 | 一种异味固体的密封包装工艺 |
JP7162363B2 (ja) * | 2020-09-29 | 2022-10-28 | Mics化学株式会社 | 積層フィルムおよび袋体 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0624571B2 (ja) * | 1988-11-21 | 1994-04-06 | 明治製菓株式会社 | 医薬品包装容器 |
SE469080B (sv) * | 1991-10-28 | 1993-05-10 | Eka Nobel Ab | Foerpackningsmaterial, foerfarande foer framstaellning av foerpackningsmaterial, anvaendning av hydrofob zeolit foer framstaellning av foerpackningsmaterial samt anvaendning av foerpackningsmaterial |
JPH08104370A (ja) * | 1994-10-04 | 1996-04-23 | Kishimoto Akira | 調理食品包装容器 |
JPH08197692A (ja) * | 1995-01-30 | 1996-08-06 | Dainippon Printing Co Ltd | ガスバリヤー積層材 |
US20040116025A1 (en) * | 2002-12-17 | 2004-06-17 | Gogins Mark A. | Air permeable garment and fabric with integral aerosol filtration |
CN1271068C (zh) * | 2003-03-25 | 2006-08-23 | 上海医药工业研究院 | 一种奥美沙坦酯的制备方法 |
JP5024718B2 (ja) | 2004-06-18 | 2012-09-12 | 東洋製罐株式会社 | 臭気捕捉用樹脂組成物 |
JP4659523B2 (ja) * | 2005-04-26 | 2011-03-30 | 共同印刷株式会社 | ブリスター用フィルム及びブリスター用包装容器 |
JP4979577B2 (ja) * | 2005-05-20 | 2012-07-18 | 第一三共株式会社 | デキストロース含有フィルムコーティング製剤 |
WO2006123765A1 (ja) * | 2005-05-20 | 2006-11-23 | Daiichi Sankyo Company, Limited | フィルムコーティング製剤 |
-
2007
- 2007-10-22 JP JP2008540976A patent/JP5241503B2/ja active Active
- 2007-10-22 KR KR1020097006803A patent/KR101400653B1/ko active IP Right Grant
- 2007-10-22 WO PCT/JP2007/070539 patent/WO2008050714A1/ja active Application Filing
- 2007-10-22 CN CN2007800395199A patent/CN101528179B/zh active Active
- 2007-10-23 TW TW096139646A patent/TWI402085B/zh active
- 2007-10-23 TW TW102113345A patent/TWI486183B/zh active
-
2013
- 2013-02-12 JP JP2013024058A patent/JP5546072B2/ja active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10994508B2 (en) | 2015-05-12 | 2021-05-04 | Innovia Films Limited | Film |
Also Published As
Publication number | Publication date |
---|---|
TW200824728A (en) | 2008-06-16 |
WO2008050714A1 (fr) | 2008-05-02 |
TWI486183B (zh) | 2015-06-01 |
CN101528179A (zh) | 2009-09-09 |
JPWO2008050714A1 (ja) | 2010-02-25 |
CN101528179B (zh) | 2013-06-26 |
JP2013121535A (ja) | 2013-06-20 |
TW201332594A (zh) | 2013-08-16 |
TWI402085B (zh) | 2013-07-21 |
KR101400653B1 (ko) | 2014-05-27 |
JP5546072B2 (ja) | 2014-07-09 |
JP5241503B2 (ja) | 2013-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5546072B2 (ja) | 包装材 | |
JP6175425B2 (ja) | Ptp又はブリスターパック用積層体及びptp又はブリスターパック | |
CA2664380C (en) | Medicinal package | |
JP5936542B2 (ja) | 包装体 | |
EP3210907B1 (en) | Laminate for blister pack, blister pack using same, blister pack package, and method for manufacturing same | |
EP3312004B1 (en) | Laminate for use in blister pack, and blister pack using same | |
KR20080009297A (ko) | Ptp 또는 블리스터 팩용 필름 및 ptp 또는 블리스터팩용 포장 용기 | |
JP2019010775A (ja) | 吸湿及びガス吸着用フィルム、並びに包装用積層体 | |
CN102438825B (zh) | 作为压穿箔用于泡罩包装的盖箔 | |
JP6832715B2 (ja) | 包装袋及びその製造方法 | |
JP7252592B2 (ja) | 包装材 | |
JP2018115010A (ja) | 吸湿及びガス吸着用フィルム並びに包装用積層体 | |
JP7002298B2 (ja) | ブリスターパック用蓋材 | |
JP2019089561A5 (ko) | ||
JP6927663B2 (ja) | 固形製剤包装体、及び固形製剤の臭い除去方法 | |
EP2127628A1 (en) | Unit dose pack | |
JP2018008729A (ja) | 包装材 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0105 | International application |
Patent event date: 20090402 Patent event code: PA01051R01D Comment text: International Patent Application |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20121018 Comment text: Request for Examination of Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20131107 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20140501 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20140521 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20140521 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20170420 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20170420 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20180502 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20180502 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20190429 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20190429 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20200506 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20210503 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20220418 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20230420 Start annual number: 10 End annual number: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20240424 Start annual number: 11 End annual number: 11 |